Literature DB >> 8430176

Renal oncocytoma and carcinoma: failure of differentiation with CT.

A J Davidson1, W S Hayes, D S Hartman, W F McCarthy, C J Davis.   

Abstract

The authors studied the hypothesis that oncocytoma and adenocarcinoma of the kidney can be differentiated with computed tomographic (CT) criteria and that differences would become more apparent as tumors enlarged. On contrast material-enhanced scans, homogeneous attenuation throughout the tumor and a central, sharply marginated, stellate area of low attenuation were considered predictors of oncocytoma. Any area of decreased attenuation in the tumor except for a stellate, central area was used as a predictor of adenocarcinoma. Among oncocytomas larger than 3 cm in diameter, 67% exhibited the criteria for oncocytoma and 33% met the criterion for adenocarcinoma; among smaller oncocytomas, the respective results were 82% and 18%. Among adenocarcinomas larger than 3 cm in diameter, 84% fulfilled the criterion for malignancy and 16% were incorrectly predicted to be oncocytomas; among smaller adenocarcinomas, the respective results were 58% and 42%. The authors conclude that the CT criteria used are poor predictors of the diagnosis of oncocytoma or adenocarcinoma regardless of tumor size.

Entities:  

Mesh:

Year:  1993        PMID: 8430176     DOI: 10.1148/radiology.186.3.8430176

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  28 in total

1.  Renal oncocytoma on 1-11C acetate positron emission tomography: Case report and literature review.

Authors:  Jabi Shriki; Venkatesh Murthy; Jeffrey Brown
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

2.  Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).

Authors:  Nicola Schieda; Maali Al-Subhi; Trevor A Flood; Mohammed El-Khodary; Matthew D F McInnes
Journal:  Eur Radiol       Date:  2014-07-17       Impact factor: 5.315

Review 3.  Review of renal cell carcinoma and its common subtypes in radiology.

Authors:  Gavin Low; Guan Huang; Winnie Fu; Zaahir Moloo; Safwat Girgis
Journal:  World J Radiol       Date:  2016-05-28

Review 4.  Solid renal masses: what the numbers tell us.

Authors:  Stella K Kang; William C Huang; Pari V Pandharipande; Hersh Chandarana
Journal:  AJR Am J Roentgenol       Date:  2014-06       Impact factor: 3.959

Review 5.  Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review.

Authors:  Nicola Schieda; Matthew D F McInnes; Lilly Cao
Journal:  Eur Radiol       Date:  2014-03-26       Impact factor: 5.315

6.  Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.

Authors:  Jay Amin; Bo Xu; Shervin Badkhshan; Terrance T Creighton; Daniel Abbotoy; Christine Murekeyisoni; Kristopher M Attwood; Thomas Schwaab; Craig Hendler; Michael Petroziello; Charles L Roche; Eric C Kauffman
Journal:  Clin Cancer Res       Date:  2018-05-11       Impact factor: 12.531

Review 7.  Update on oncocytoma.

Authors:  Stephen M Schatz; Michael M Lieber
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

8.  Adrenocortical oncocytoma -- a rare tumor of undefined malignant potential: report of a case.

Authors:  Dimitrios Botsios; Konstantinos Blouhos; Konstantinos Vasiliadis; Anthoula Asimaki; Konstantinos Tsalis; Dimitrios Betsis
Journal:  Surg Today       Date:  2007-06-26       Impact factor: 2.549

9.  The current role of renal biopsy in the management of localized renal tumors.

Authors:  Gagan Gautam; Kevin C Zorn
Journal:  Indian J Urol       Date:  2009 Oct-Dec

Review 10.  Imaging and management of the incidentally discovered renal mass.

Authors:  Jonathon Willatt; Isaac R Francis
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.